Future of Oligonucleotide Synthesis Market Global Forecast to 2022

The growth of this market is mainly driven by the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.

The global oligonucleotide synthesis market is valued at USD 1.33 Billion in 2016 and is projected to reach USD 2.46 Billion by 2022, at a CAGR of 10.9%. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350

This report segments the market into product, application, end user, and region

Target Audience for this Report:

• Life science instrumentation and reagent companies
• Pharmaceutical and biotechnology companies
• Hospitals and clinics
• Academic researchers and government research organizations
• Private research institutes
• Custom oligonucleotide service providers
• Contract manufacturing organizations (CMOs)
• Oligonucleotide equipment manufacturers
• Contract research organizations (CROs)
• Market research and consulting firms
• Venture capitalists

The oligonucleotide synthesis market is highly competitive with the presence of several small and big players. 

Prominent players in the market include Integrated DNA Technologies (IDT) (US), Sigma-Aldrich Corporation (US) (part of Merck KGaA), Eurogentec (Belgium), Eurofins Genomics (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), BioAutomation (US), LGC Biosearch Technologies (US), GeneDesign (Japan), GE Healthcare (US), TriLink BioTechnologies (US), GenScript (China), Nitto Denko Avecia (US), ATDBio (UK), Bio-Synthesis (US), IBA GmbH (Germany), Gene Link (US), and AITbiotech Pte. (Singapore)

To Know More @ https://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

Increasing Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications

The growth of oligonucleotide synthesis market is mainly driven by the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.

The global oligonucleotide synthesis market is expected to reach USD 2.46 Billion by 2022 from USD 1.47 Billion in 2017 at a CAGR of 10.9%. 

This report segments the market into product, application, end user, and region. 

Based on product, the market is segmented into synthesized oligonucleotides, reagents, and equipment. In 2017, synthesized oligonucleotides are estimated to account for the largest share of the total market, followed by reagents. The growth of the synthesized oligonucleotides segment is attributed to the increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=200829350

Based on product, the synthesized oligonucleotides market is segmented into primers, probes, large-scale synthesis oligonucleotides, intermediate-scale synthesis oligonucleotides, and linkers & adaptors. Primers are expected to account for the largest share of the synthesized oligonucleotides market in 2017. The intermediate-scale synthesis oligonucleotides segment is projected to register the highest CAGR, due to the rising demand for synthesized oligonucleotides and innovations in manufacturing techniques to produce intermediate-scale oligonucleotides.

Based on end user, the oligonucleotide synthesis market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. The diagnostic laboratories segment is expected grow at the highest CAGR during the forecast period. This growth is attributed to the rising diagnostic applications of oligonucleotides and the growing field of molecular diagnostics.